| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | 10x Genomics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| Di | 10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results | 97 | PR Newswire | PLEASANTON, Calif., April 30, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March... ► Artikel lesen | |
| 21.03. | 10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel | 861 | PR Newswire | Begins commercial shipments of Xenium Cell Segmentation Kit to improve determination of cell boundaries
Launches first Xenium application-focused panel optimized for immuno-oncology across all tissue... ► Artikel lesen | |
| 13.03. | 10x Genomics, Inc: 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products | 317 | PR Newswire | The next generation of the company's leading single cell technology architecture, GEM-X, enables higher performance at larger scale and lower cost
PLEASANTON, Calif., March 13, 2024 /PRNewswire/... ► Artikel lesen | |
| 16.02. | 10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript | 5 | Insider Monkey | ||
| 16.02. | 10X Genomics Inc reports results for the quarter ended in December - Earnings Summary | 7 | Reuters | ||
| 15.02. | 10x Genomics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 15.02. | 10x Genomics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 15.02. | 10x Genomics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.02. | 10x Genomics, Inc: 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024 | 855 | PR Newswire | Q4 2023 revenue growth of 18% and FY 2023 revenue growth of 20% over the corresponding periods of 2022
PLEASANTON, Calif., Feb. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader... ► Artikel lesen | |
| 16.01. | 10x Genomics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 08.01. | 10x Genomics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.01. | 10x Genomics, Inc.: 10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results | 182 | PR Newswire | PLEASANTON, Calif., Jan. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.814 |
| NEL | 1.629 |
| APPLE | 1.513 |
| BAYER | 1.477 |
| BYD | 1.469 |
| SUPER MICRO COMPUTER | 1.353 |
| DEUTSCHE BANK | 1.234 |
| TUI | 1.210 |
| NVIDIA | 1.207 |
| PLUG POWER | 1.064 |
| TESLA | 1.016 |
| DAIMLER TRUCK | 934 |
| MERCEDES-BENZ | 911 |
| RHEINMETALL | 889 |
| RWE | 888 |
| AURUBIS | 801 |
| RENK GROUP | 779 |
| DEUTSCHE LUFTHANSA | 776 |
| COMMERZBANK | 756 |
| VOLKSWAGEN | 755 |
| AMAZON | 743 |
| SIEMENS ENERGY | 689 |
| AIXTRON SE | 665 |
| SIXT SE VZ | 648 |
| BASF | 612 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
